Stable preparation for the treatment of blood coagulation disord

Details Stable preparation for the treatment of blood coagulation disord Stable preparation for the treatment of blood coagulation disord

1997-09-05

2000-01-25

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 78, 424450, A61F 3800, A01N 5726, A61K 9127

Patent

active

060178914

ABSTRACT:
The invention relates to a stable preparation which comprises a protein, such as thrombin, that is bound in and/or on (i.e., to) lipid vesicles and that was treated for the inactivation of potentially present viruses. Further, the invention relates to methods for the production of a stable preparation for the treatment of blood coagulation disorders, wherein a protein is bound in and/or on lipid vesicles, and the method comprises a step in which the protein lipid complex is subjected to a treatment for the inactivation of potentially present viruses.

REFERENCES:
patent: 4241046 (1980-12-01), Papahadjopoulos et al.
patent: 4348384 (1982-09-01), Horikosi et al.
patent: 4610880 (1986-09-01), Giles et al.
patent: 4640834 (1987-02-01), Eibl et al.
patent: 4721618 (1988-01-01), Giles et al.
patent: 4937324 (1990-06-01), Fujikawa et al.
patent: 5198349 (1993-03-01), Kaufman
patent: 5206023 (1993-04-01), Hunziker
patent: 5225537 (1993-07-01), Foster
patent: 5354682 (1994-10-01), Kingdon et al.
patent: 5368858 (1994-11-01), Hunziker
patent: 5418130 (1995-05-01), Platz et al.
patent: 5698677 (1997-12-01), Eibl et al.
Bajaj et al. J. of Biol. Chem., vol. 248, No. 22, pp. 7729-7741 (1973).
Barenholz et al. Biochemistry 16: 2806-2810 (1977).
Barrowcliffe Medline Abstract 94229366 (1993).
Batzri et al. Biochimica et Biophysica Acta 298: 1015-1019 (1973).
Bloom et al. Biochemistry 18(20): 4419-25 (1979).
Brummelhuis Methods of Plasma Protein Fractionation, pp. 117-125, Acad. Press (1980).
Burri et al. Biochimica et Biophysica Acta 923: 176-86 (1987).
Duffy et al. J. of Biological Chemistry 267(24): 17006-17011 (1992).
Giles et al. Blood 59(2): 401-407 (1982).
Hope et al. Biochimica et Biophysica Acta 812: 55-65 (1985).
Juliano et al. Lipsome Technology, 2nd Ed., vol. III, 15-25 (1993).
Lindhout et al. Biochemistry 21: 5494-5502 (1982).
Olson et al. Biochimica et Biophysica Acta 557: 9-23 (1979).
Papahadjopoulos Liposome Technology, 2nd ed., vol. III, pp. 2-13 (1993).
Szoka et al. Proc. Natl. Acad. Sci. USA 75(9): 4194-4198 (1978).
Teng et al. Thombosis Research 22: 213-220 (1981).
Tidrick et al. Surgery 14: 191-196 (1943).
Weiner et al. Journal of Drug Targeting 2: 405-410 (1994).
Zumbuehl et al. Biochimica et Biophysica Acta 640: 252-262 (1981).
Raiz etal, Pharm Dosage Forms; Dipense System 2: 567-602 ch 16, Lieberman et al ed; Marcel Dekker NY, 1988.
Siekmann, "Clinical Experience with Thrombin as an Hemostatic Agen" Surgery14:191-196 (1943).
Riaz et al., Pharmaceutical Dosage Forms: Dispense Systems 2:567-603 (1988), Ch 16 Marcel Dekker, New York, Lieberman et al Ed.
Giles et al., "A Canine Model of Himophilic (Factor VIII:C Deficiency) Bleeding" Blood 60:727-730 (1982).

Affiliated with

Also associated with

Rating

Stable preparation for the treatment of blood coagulation disord does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable preparation for the treatment of blood coagulation disord, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable preparation for the treatment of blood coagulation disord will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2316006